Dabigatran Etexilate and Insulin Glargine (U-300) Pens
Determining the interaction of Dabigatran Etexilate and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabigatran
Brand name: Pradaxa
Synonyms: Dabigatran
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabigatran Etexilate-Insulin glargine and lixisenatide
- Dabigatran Etexilate-Insulin glargine and lixisenatide Subcutaneous
- Dabigatran Etexilate-Insulin glargine, recombinant Subcutaneous
- Dabigatran Etexilate-Insulin glulisine
- Dabigatran Etexilate-Insulin Glulisine (Cartridges and Pens)
- Dabigatran Etexilate-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Dabigatran Etexilate Mesylate
- Insulin Glargine (U-300) Pens-Dabrafenib
- Insulin Glargine (U-300) Pens-Dabrafenib Mesylate
- Insulin Glargine (U-300) Pens-Dacarbazine
- Insulin Glargine (U-300) Pens-Dacarbazine Intravenous, Injection
- Insulin Glargine (U-300) Pens-Daclatasvir